UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
SNUBH wins $5 million contract for hospital information system
Seoul National University Bundang Hospital분당서울대병원(SNUBH) has won a $5-milli...
by Choi Gwang-seok
|
2017-05-15 17:11
라인
P2 trial over for GemVax’s prostate disease drug
GemVax & KAEL (CEO: Kim Sang-Jae김상재) completed its phase two clinical trial...
by Marian Chu
|
2017-05-15 11:00
라인
Government’s bio investment focuses on new drugs
The government has funneled about 10 percent of its fiscal spending on the ...
by Nam Doo-hyun
|
2017-05-12 13:55
라인
Doctors must wear name tags or face fines
A new law that makes name tags mandatory for medical professionals went int...
by Marian Chu
|
2017-05-12 12:10
라인
Will a former doctor become Moon’s first health minister?
As President Moon Jae-in has set about to form his first Cabinet, healthcar...
by Kwak Sung-sun
|
2017-05-12 11:07
라인
‘Korean pharmaceuticals should expand US export with new drugs’
With the United States stepping up protectionist measures, a state agency h...
by Nam Doo-hyun
|
2017-05-11 17:18
라인
Roche’s bladder cancer drug fails P3 trial
Roche’s Tecentriq (compound: atezolizumab), the first immunotherapeutic bla...
by Constance Williams
|
2017-05-11 16:25
라인
Gilead Sciences keeps on rolling in Korea: Why?
When the news spread six years ago that Gilead Sciences길리어드 would enter the...
by Park Gi-taek
|
2017-05-11 14:52
라인
Celltrion adds reason why Remsima can target US market
Celltrion has secured additional grounds for its biosimilar Remsima, called...
by Constance Williams
|
2017-05-11 11:50
라인
Investors focus on Moon-related shares
The news of Moon Jae-in’s election victory is jolting the stock market, too...
by Nam Doo-hyun
|
2017-05-10 20:02
라인
Industry groups ask Moon to expand policy support
As President Moon Jae-in steps into the Blue House, various healthcare-rela...
by Marian Chu
|
2017-05-10 17:30
라인
Changes in healthcare policy expected under President Moon
Moon Jae-in started his term as the 19th president of the Republic of Korea...
by Marian Chu
|
2017-05-10 15:53
라인
FDA gives accelerated approval to bladder cancer drug
The U.S. Food and Drug Administration granted accelerated approval Tuesday ...
by Constance Williams
|
2017-05-10 11:11
라인
Korea’s share remains small in multinational pharmaceuticals’ operation
What is the proportion of the Korean market among multinational pharmaceuti...
by Marian Chu and Nam Doo-hyun
|
2017-05-09 02:53
라인
Act on ‘well-dying’ caught up in controversy
After much difficulty, the government has enacted a law that gives patients...
by Song Soo-youn
|
2017-05-08 18:06
라인
Druggists up in arms over increase of medicines sold at convenience stores
Pharmacies around the globe are retailing two categories of drugs: Over the...
by Constance Williams
|
2017-05-04 13:35
라인
Can Jardiance threaten Forxiga's dominance in treating diabetes?
Korean regulators have officially recognized the effect of SGLT-2 (sodiumgl...
by Park Gi-taek
|
2017-05-04 13:30
라인
Dilemma of professional manager system: Yuhan, Samjin
Free from owner’s influence, CEO Lee Jung-hee of Yuhan Corp. struggles unde...
by Lee Hye-seon
|
2017-05-04 09:26
라인
‘Korean drug market to grow twice faster than GDP until 2021’
Korea’s pharmaceutical market is likely to grow 4.4 percent on annual avera...
by Lee Hye-seon
|
2017-05-02 14:33
라인
Did Park's confidante appoint health-welfare minister, too?
Various circumstances indicate Choi Soon-sil, the 40-year-long confidante o...
by Song Soo-youn
|
2017-05-02 11:46
-
이전
311
312
313
314
315
316
317
318
319
320
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top